American National Registered Investment Advisor’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$737K Sell
2,767
-1,401
-34% -$344K 0.26% 112
2021
Q4
$1.11M Hold
4,168
0.37% 75
2021
Q3
$1.19M Sell
4,168
-6
-0.1% -$1.71K 0.43% 70
2021
Q2
$1.15M Sell
4,174
-106
-2% -$28.8K 0.41% 71
2021
Q1
$1.12M Sell
4,280
-7
-0.2% -$1.88K 0.43% 64
2020
Q4
$1.1M Sell
4,287
-1,468
-26% -$364K 0.44% 66
2020
Q3
$1.36M Hold
5,755
0.62% 44
2020
Q2
$1.12M Hold
5,755
0.56% 49
2020
Q1
$953K Hold
5,755
0.59% 48
2019
Q4
$985K Hold
5,755
0.49% 66
2019
Q3
$949K Hold
5,755
0.52% 58
2019
Q2
$687K Hold
5,755
0.39% 82
2019
Q1
$547K Buy
+5,755
New +$493K 0.3% 109

Other funds holding PODD

American National Registered Investment Advisor's PODD Position: Q1 2022 in Review

American National Registered Investment Advisor reduced its Insulet (PODD) stake by 34% in Q1 2022, selling an estimated $344K and leaving 2,767 shares worth $737K. The position accounts for 0.26% of the portfolio, ranked #112.

American National Registered Investment Advisor first reported a position in PODD in Q1 2019 and has held it in 13 quarters since. The position peaked at $1.36M in Q3 2020. 483 funds tracked by Wall St. Rank hold PODD as of Q1 2022.

  • American National Registered Investment Advisor held 2,767 shares of Insulet worth $737K as of Q1 2022.
  • American National Registered Investment Advisor sold 1,401 Insulet shares in Q1 2022, an estimated $344K.
  • Insulet made up 0.26% of American National Registered Investment Advisor's portfolio in Q1 2022, its #112 holding.
  • American National Registered Investment Advisor first reported a position in Insulet in Q1 2019 and has held it in 13 quarters since.
  • American National Registered Investment Advisor's Insulet position peaked at $1.36M in Q3 2020.
  • 483 funds tracked by Wall St. Rank held Insulet as of Q1 2022.

Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.